Scaly Papules – Friday Pop Quiz 3/31/2023
A 55-year-old patient from the Caribbean presents with indurated scaly papules and plaques on his trunk, arms, and legs. The rash started six months ago and has progressed rather quickly. Review of system was notable for pruritus and xerosis; patient reported no personal history of skin diseases, including psoriasis and atopic dermatitis. Several 4-mm punch biopsies were performed. Based on th …
Friday Pop Quiz #212
The correct answer is C. IL-36. IL-36. Spesolimab is a novel, selective humanized anti–interleukin-36 receptor monoclonal antibody recently approved by the for the treatment of adults with GPP.1 IL-17 inhibitors approved for plaque psoriasis include secukinumab, ixekizumab, and brodalumab. Bimekizumab is also an IL-17 inhibitor in ongoing clinical trials for plaque psoriasis. IL-23 inh …
Apremilast Therapeutic Cheat Sheet
apremilastApremilast (OTEZLA®) is a twice daily oral medication that is FDA approved for adults with plaque psoriasis, psoriatic arthritis and oral ulcers associated with Behçet’s Disease.1 This drug is being extended as an off-label treatment to target inflammation in a number of different conditions. This Therapeutic Cheat Sheet will focus on apremilast and its applications for different dermatologica …
apremilast
Keloids: Medical Treatment Strategies with Dr. Kerby
keloidsNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Eva Kerby, assistant professor of clinical dermatology at Weill Cornell Medical College. Dr. Kerby shares her preferred medical treatment options for  keloids, and why it’s important to set treatment expectations with patients. Watch as Dr. Kerby shares tips for good injection technique and how to treat larger, nodul …
keloids
JDD February 2023 Issue Highlights
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale …
error

Enjoy this blog? Please spread the word :)